Lutetium-177 Dotatate Peptide Receptor Radionuclide Therapy in metastatic pheochromocytoma and paraganglioma: Experience in our center

被引：0
|
作者：
Negre, M. [1 ]
Guardeno, R. [1 ]
Biarnes, J. [1 ]
Recasens, M. [1 ]
Rubio, A. [1 ]
机构：
[1] Hosp Univ Girona Dr Josep Trueta, Girona, Spain
来源：
JOURNAL OF NEUROENDOCRINOLOGY | 2024年 / 36卷
关键词：
prrt; 177lu-dotatate; metastatic paraganglioma; metastatic pheochromocytoma;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
H13
引用
收藏
页码：210 / 210
页数：1
相关论文
共 50 条
  • [1] Peptide Receptor Radionuclide Therapy (177Lutetium DOTATATE) as a Treatment Modality for Metastatic Phaeochromocytoma (PCC) and Paraganglioma (PGL)
    Armeni, E.
    Sullivan, L.
    Quigley, A. M.
    Navalkissoor, S.
    Caplin, M.
    Hayes, A. R.
    Grossman, A. B.
    Khoo, B.
    Toumpanakis, C.
    NEUROENDOCRINOLOGY, 2019, 108 : 197 - 197
  • [2] 177Lu-DOTATATE therapy in metastatic/inoperable pheochromocytoma-paraganglioma
    Jaiswal, Sanjeet Kumar
    Sarathi, Vijaya
    Memon, Saba Samad
    Garg, Robin
    Malhotra, Gaurav
    Verma, Priyanka
    Shah, Ravikumar
    Sehemby, Manjeet Kaur
    Patil, Virendra A.
    Jadhav, Swati
    Lila, Anurag Ranjan
    Shah, Nalini S.
    Bandgar, Tushar R.
    ENDOCRINE CONNECTIONS, 2020, 9 (09): : 864 - 873
  • [3] Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye
    Unal, Caglar
    Selcuk, Nalan Alan
    Biricik, Fatih Selcuk
    Alan, Ozkan
    Ordu, Cetin
    Selvi, Oguzhan
    Sakin, Abdullah
    Sever, Nadiye
    Topcu, Zeynep Alaca
    Akyildiz, Arif
    Coban, Eyup
    Evrensel, Turkan
    Ozcan, Erkan
    Dursun, Bengu
    Yucel, Kadriye Bir
    Arak, Haci
    On, Sercan
    Guzel, Halil Goksel
    Salim, Derya Kivrak
    Kalkan, Ziya
    Oruc, Zeynep
    Duymaz, Tomris
    Seyyar, Mustafa
    Agdas, Gozde
    Ozcelik, Melike
    Paksoy, Nail
    Cetin, Bulent
    Yararbas, Kanay
    Saglam, Sezer
    EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY, 2023, 7 (03): : 232 - 242
  • [4] Efficacy of 177-Lutetium DOTATATE Peptide Receptor Radionuclide Therapy in patients with metastatic NENs and carcinoid syndrome refractory to somatostatin analogues
    Ratnayake, G. M.
    Koffas, A.
    Theocharopoulos, I
    Hayes, A.
    Navalkissoor, S.
    Gnanasegaran, G.
    Quigley, A. M.
    Khoo, B.
    Mandair, D.
    Grossman, A.
    Caplin, M.
    Alsadik, S.
    Clark, R.
    Toumpanakis, C.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 157 - 157
  • [5] A single institution experience with peptide receptor radionuclide therapy (PRRT) in advanced pheochromocytoma and paraganglioma
    Duan, H.
    Ferri, V
    Fisher, G.
    Shaheen, S.
    Davidzon, G.
    Moradi, F.
    Nguyen, J.
    Franc, B.
    Iagaru, A.
    Mari, Aparici C.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 180 - 180
  • [6] Hepatic complications of peptide receptor radionuclide therapy with Lutetium-177 and Yttrium-90 in patients with neuroendocrine neoplasm
    Bober, Barbara
    Saracyn, Marek
    Lubas, Arkadiusz
    Kolodziej, Maciej
    Brodowska-Kania, Dorota
    Kapusta, Waldemar
    Kaminski, Grzegorz
    NUCLEAR MEDICINE REVIEW, 2022, 25 (01) : 54 - 61
  • [7] Peptide Receptor Radionuclide Therapy With 177Lu DOTATATE in a Case of Recurrent Carotid Body Paraganglioma With Spinal Metastases
    Gupta, Santosh Kumar
    Singla, Suhas
    Karunanithi, Sellam
    Damle, Nishikant
    Bal, Chandrasekhar
    CLINICAL NUCLEAR MEDICINE, 2014, 39 (05) : 440 - 441
  • [8] Validation of an in-house developed therapeutic dosimetric software tool for the treatment of 177Lutetium-DOTATATE peptide receptor radionuclide therapy
    Bronwin Van Wyk
    Francis Hasford
    Nozipho Nyakale
    Mboyo-Di-Tamba Vangu
    Health and Technology, 2024, 14 : 277 - 289
  • [9] Validation of an in-house developed therapeutic dosimetric software tool for the treatment of 177Lutetium-DOTATATE peptide receptor radionuclide therapy
    Van Wyk, Bronwin
    Hasford, Francis
    Nyakale, Nozipho
    Vangu, Mboyo-Di-Tamba
    HEALTH AND TECHNOLOGY, 2024, 14 (02) : 277 - 289
  • [10] Dosimetry in Lu-177-DOTATATE peptide receptor radionuclide therapy: a systematic review
    Nautiyal, Amit
    Michopoulou, Sofia
    Guy, Matt
    CLINICAL AND TRANSLATIONAL IMAGING, 2024, 12 (02) : 157 - 175
12345